Alkermes (ALKS) Current Deferred Revenue (2011 - 2025)
Alkermes (ALKS) reported Current Deferred Revenue of $578,000 for Q2 2025, down 82.5% from $3.31 million a year earlier and down 64.1% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Current Deferred Revenue (2011 - 2025) Analysis & Trends
At the end of FY2024, Alkermes posted Current Deferred Revenue of $1.25 million, down 54.2% from FY2023.
- Current Deferred Revenue has a five-year compound annual growth rate of -28.7% (FY2019 to FY2024).
- By year, Current Deferred Revenue came in at $2.73 million in FY2023 (-59.9%), $6.82 million in FY2022 (+7.5%), $6.34 million in FY2021 (-15.6%) and $7.51 million in FY2020 (+11.0%).
- The Q2 2025 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q1 2013.
- Year over year, Current Deferred Revenue has now declined in each of the last four quarters, with an average decline of 30.3% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q3 2020 (growth of 297.8%); the low point was Q2 2025 (a decline of 82.5%).
- Per Business Quant data, the three quarters before Q2 2025 came in at $1.61 million (Q1 2025), $1.25 million (Q4 2024) and $2.34 million (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 578,000.00 |
| Mar 31, 2025 | 1.61 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 3.32 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | 6.82 Mn |
| Sep 30, 2022 | 3.98 Mn |
| Jun 30, 2022 | 3.79 Mn |
| Mar 31, 2022 | 4.92 Mn |
| Dec 31, 2021 | 6.34 Mn |
| Sep 30, 2021 | 6.40 Mn |
| Jun 30, 2021 | 6.63 Mn |
| Mar 31, 2021 | 7.92 Mn |
| Dec 31, 2020 | 7.51 Mn |
| Sep 30, 2020 | 7.15 Mn |
API Access
Alkermes Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();